Letter: Adropin as a Novel Biomarker of Endothelial Dysfunction in Patients With Preeclampsia

Abstract

Get full access to this article

View all access options for this article.

References

Karaca

Ercan

Akdemir

, et al. The evaluation of adropin and Autotaxin as potential markers of endothelial dysfunction in preeclampsia. Angiology. 2024;75:779-785.

Cakmak

Dundar

Acikgoz

, et al. The relationship between maternal and umbilical cord adropin levels with the presence and severity of preeclampsia. J Perinat Med. 2017;45:879-885.

Wang

Gao

Wang

Dong

. Alteration of serum adropin level in preeclampsia. Pregnancy Hypertens. 2017;8:6-8.

Aydin

Eser

Kaygusuz

, et al. Adipokine, adropin and endothelin-1 levels in intrauterine growth restricted neonates and their mothers. J Perinat Med. 2016;44(6):669-676.

Baka

Malamitsi-Puchner

Briana

, et al. Adropin concentrations in term pregnancies with normal, restricted and increased fetal growth. J Matern Fetal Neonatal Med. 2016;29:2403-2407.

Celik

Yilmaz

Celik

, et al. Maternal and fetal adropin levels in gestational diabetes mellitus. J Perinat Med. 2013;41:375-380.

Zhu

, et al. Inverse correlation between plasma adropin and ET-1 levels in essential hypertension: a cross-sectional study. Medicine (Baltim). 2015;94:e1712.

Lovren

Pan

Quan

, et al. Adropin is a novel regulator of endothelial function. Circulation. 2010;122(11 Suppl): S185-S192.